Aktis Oncology, Inc. (AKTS)
18.15
+0.41
(+2.31%)
USD |
NASDAQ |
Oct 09, 16:00
18.14
-0.02
(-0.08%)
After-Hours: 20:00
Aktis Oncology Total Liabilities (Quarterly) : 72.76M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.76M |
| March 31, 2026 | 70.69M |
| December 31, 2025 | 82.75M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 85.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 557.60M |
| Shareholders Equity (Quarterly) | 484.84M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 16.33 |
| Net Debt Paydown Yield | 0.01% |